On Nov 05, major Wall Street analysts update their ratings for $LyondellBasell Industries (LYB.US)$, with price targets ranging from $92 to $110.
J.P. Morgan analyst Jeffrey Zekauskas maintains with a buy rating, and adjusts the target price from $110 to $100.
BofA Securities analyst Steve Byrne maintains with a hold rating, and adjusts the target price from $101 to $96.
Citi analyst Patrick Cunningham, CFA maintains with a hold rating, and adjusts the target price from $100 to $92.
Barclays analyst Michael Leithead maintains with a hold rating, and adjusts the target price from $99 to $95.
Deutsche Bank analyst David Begleiter maintains with a hold rating, and adjusts the target price from $110 to $94.
Furthermore, according to the comprehensive report, the opinions of $LyondellBasell Industries (LYB.US)$'s main analysts recently are as follows:
The chemical markets are perceived to be at a 'prolonged trough' following the Q3 report.
The outlook and results for LyondellBasell's O&P - Americas continue to be largely favorable, with the strongest order books of the year reported in October. The potential for a recovery to a higher valuation is observed, supported by an attractive mid-cycle EBITDA multiple.
Expectations for the quarter were moderated in light of underwhelming earnings from comparable companies, resulting in a relatively neutral market reaction to the company's third-quarter performance shortfall and subdued fourth-quarter forecast. The positive stance on the company's shares persists, underpinned by the anticipation of a chemicals industry rebound, a robust capital return framework, and comparatively modest capital expenditures in relation to industry counterparts.
Here are the latest investment ratings and price targets for $LyondellBasell Industries (LYB.US)$ from 9 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間11月5日，多家華爾街大行更新了$利安德巴塞爾 (LYB.US)$的評級，目標價介於92美元至110美元。
摩根大通分析師Jeffrey Zekauskas維持買入評級，並將目標價從110美元下調至100美元。
美銀證券分析師Steve Byrne維持持有評級，並將目標價從101美元下調至96美元。
花旗分析師Patrick Cunningham, CFA維持持有評級，並將目標價從100美元下調至92美元。
巴克萊銀行分析師Michael Leithead維持持有評級，並將目標價從99美元下調至95美元。
德意志銀行分析師David Begleiter維持持有評級，並將目標價從110美元下調至94美元。
此外，綜合報道，$利安德巴塞爾 (LYB.US)$近期主要分析師觀點如下：
根據第三季度報告，化學品市場被認爲處於'持續低谷'。
從結果來看，LyondellBasell的O&P - 美洲的前景和業績依然大體上保持樂觀，十月份報告顯示訂單書中有全年最強勁的訂單。觀察到公司股票有望恢復到更高估值水平，這得益於具有吸引力的中期EBITDA倍數。
鑑於類似公司盈利表現不佳，對本季度的預期有所抑制，使得市場對公司第三季度業績不佳和第四季度預期疲軟的反應相對中立。對公司股票的積極立場仍然存在，支撐因化學品行業的復甦預期、強大的資本回報框架以及相對於行業同行的較低資本支出水平。
以下爲今日9位分析師對$利安德巴塞爾 (LYB.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
